Volume 26, Issue 8 (11-2019)                   RJMS 2019, 26(8): 89-95 | Back to browse issues page

XML Persian Abstract Print


Deptartment of Emergency Medicine, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran , kabiri_t@yahoo.com
Abstract:   (3794 Views)
Background: Ascites is characterized by excess fluid accumulation in the peritoneal cavity. In assessing a patient with ascites, it is necessary to determine the cause due to the very different causes of ascites, the importance of knowing its causes and finally the unknown status of the disease in the area. In order to determine the causes ascites and the role of age, sex, and other causes we reviewed the causes and the reasons for the visit patients with ascites admitted to the emergency department of Rasoul Akram and Firoozgar Hospitals.
Methods: This is a descriptive cross-sectional study. In this study, the files of all patients referred to Firoozgar and Rasoul Akram hospitals during 5 years from 2010 to 2015 were evaluated. Data including demographic information, such as age, sex, etc., and clinical information such as cause, drug use, number of years of illness and etc were collected using a pre-designed checklist. Data were analyzed using SPSS version 21 software.
Results: A total of 427 participants with ascites (48% male and 42% female) were enrolled. The most common cause of referral to hospital was abdominal pain (36.8%) and then increased abdominal girth (20.8%). The most common complication in hospitalized patients with ascites was SBP.
Conclusion: Since SBP can be a life-threatening complication, early diagnosis and prompt treatment should be ensured. Further large-scale studies are suggested.
 
Full-Text [PDF 713 kb]   (974 Downloads)    
Type of Study: Research | Subject: Urgent Medicine

References
1. 1. Caly WR, Abreu RM, Bitelman B, Carrilho FJ, Ono SK. Clinical Features of Refractory Ascites in Outpatients. Clinics; 2017.72(7):405-10.
2. 2. Zandi M, Alavian SM, Memarian R, Kazem Nejad A. Assessment of the Effect of Self Care Program on Quality of Life in Patients with Cirrhosis referred to Tehran Hepatitis Center in 2003. Razi J Med Sci; 2004.11(41):411-20.
3. 3. Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, et al. The management of ascites in
4. cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology; 2003.38(1):258-66.
5. 4. Liver EAFTSOT. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol; 2010.53(3):397-417.
6. 5. Tasneem H, Shahbaz H, Sherazi BA. Pharmacoepidemiology of ascites and associated complications in hospitalized patients: descriptive observational study. Int Curr Pharm J; 2015.4(2):343-6.
7. 6. Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. Hepatology; 2009.49(6):2087-107.
8. 7. Heuman DM, Abou‐Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology; 2004.40(4):802-10.
9. 8. Dever J, Sheikh M. spontaneous bacterial peritonitis–bacteriology, diagnosis, treatment, risk factors and prevention. Alimen Pharmacol Ther; 2015.41(11):1116-31.
10. 9. Senousy BE, Draganov PV. Evaluation and management of patients with refractory ascites. World J Gastroenterol; 2009.15(1):67.
11. 10. Shizuma T. Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review. World J Hepatol; 2018.10(2):254.
12. 11. Ghahramani S, Bolukani S. Survey of valuability of sonographic gall bladder wall patterns in differentiating cirrhotic from malignant ascites. Razi J Med Sci; 2002.8(27):597-601.
13. 12. Muir AJ. Understanding the complexities of cirrhosis. Clin Ther; 2015.37(8):1822-36.
14. 13. Planas R, Montoliu S, Ballesté B, Rivera M, Miquel M, Masnou H, et al. Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol; 2006.4(11):1385-94. e1.
15. 14. Mohammadi A, Ghasemi-Rad M, Mohammadifar M. Differentiation of benign from malignant induced ascites by measuring gallbladder wall thickness. Maedica; 2011.6(4):282.
16. 15. Wang TF, Hwang SJ, Lee FY, Tsai YT, Lin HC, Li CP, et al. Gall‐bladder wall thickening in patients with liver cirrhosis. J Gastroenterol Hepatol; 1997.12(6):445-9.
17. 16. Miroliaee A, Barikani A, Hajaghamohammadi A, Zargar A, Mircheraghy F. Ascite Fluid Survey in Admitted Patients at Bu-Ali and Velayat Hospitals in Qazvin During the Years of 2011-2013. J Ilam Uni Med Sci; 2016.23(7):60-68.
18. 17. Sharify H, Hamidy G, Esfahany A. Evaluation of ascitic fluid chractristics and etiology in patient hospitalized at Shahid Beheshty hospital Kashan between 1372-1379. Feyz J Kashan Uni Med Sci; 2002.18:65-70.
19. 18. Ghanaei F, Mashhour M, Bagherzadeh A, Shafaghi A. Evaluation of ascites in patients with low gradient in Rasht during 1374-1380. Feyz J Kashan Uni Med Sci; 2006.34:24-7.
20. 19. Orman ES, Hayashi PH, Bataller R, Barritt IV AS. Paracentesis is associated with reduced mortality in patients hospitalized with cirrhosis and ascites. Clin Gastroenterol Hepatol; 2014.12(3):496-503. e1.

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.